Near Infrared Imaging Market Set for Rapid Growth, Demand, Scope, Size, Share, Forecast 2030
Near Infrared Imaging Market Overview:
The global near-infrared
(NIR) imaging market is projected to grow at a CAGR of
approximately 7–8% over the next five years. This growth is driven by the
rising burden of chronic diseases, the clinical advantages of NIR imaging over
conventional imaging modalities, continuous technological advancements, and the
expanding use of NIR imaging in medical research. Increasing adoption of NIR
imaging in surgical procedures, coupled with a growing volume of surgeries
worldwide, supportive regulatory frameworks, and initiatives promoting advanced
medical imaging technologies further support market expansion. Additionally,
the adoption of hybrid NIR imaging modules for surgical guidance and molecular
imaging is accelerating market growth.
Download Sample PDF Copy: https://meditechinsights.com/near-infrared-imaging-market/request-sample/
Near Infrared Imaging (NIR imaging) is
a non-invasive technique that uses near-infrared light in the 700–900 nm range
to visualize biological tissues. By capturing the interaction between NIR light
and tissue, the technology enables visualization of anatomical structures,
blood flow, and molecular markers. NIR imaging is widely used in applications
such as cancer detection, vascular imaging, brain imaging, and intraoperative
monitoring of tissue oxygenation. Its ability to provide real-time
visualization with high sensitivity and minimal tissue damage makes it a
valuable tool in both clinical diagnostics and medical research.
Integration with Other Technologies Creates Significant Growth
Opportunities
The integration of NIR imaging with
advanced technologies such as MRI, PET, and artificial intelligence presents
substantial growth potential. Combining NIR imaging with MRI or PET systems
enhances diagnostic accuracy by delivering complementary anatomical and
functional information. Meanwhile, AI-driven image processing and analytics
improve real-time decision-making and automated detection of abnormalities.
This convergence enables more efficient workflows, improved diagnostic
precision, and personalized treatment planning. As a result, NIR imaging is
expected to expand its clinical footprint across specialties including oncology
and neurology, ultimately improving patient outcomes through more targeted and
data-driven healthcare solutions.
As noted by a director at a leading
U.S. medical imaging equipment manufacturer, the integration of NIR imaging
with advanced data-driven algorithms in portable devices represents a major
technological breakthrough. Its simplicity, non-invasive nature, and
cost-effectiveness allow NIR imaging to complement high-cost modalities such as
fMRI, PET, and CT, enhancing diagnostic capabilities across a wide range of
medical applications.
Technological Innovations Driving Market Adoption
Ongoing technological innovation is
accelerating the adoption of NIR imaging by improving image quality, system
performance, and usability. Advances in sensor technology and optics have
significantly enhanced sensitivity and resolution, enabling more precise tissue
visualization. Research efforts focused on advanced detection technologies,
improved processing algorithms, and seamless integration with MRI and CT
systems are further strengthening imaging accuracy and data depth.
The development of advanced
fluorescent dyes and contrast agents has improved specificity in molecular
imaging applications. In parallel, device miniaturization and the integration
of NIR imaging into portable and point-of-care systems are expanding
accessibility in clinical settings. These innovations are broadening the scope
of NIR imaging in diagnostics and surgery, supporting better patient outcomes
through precise and non-invasive techniques. The growing emphasis on
personalized medicine and continuous patient monitoring, along with emerging
interest in biometric security and wearable health technologies, further
underscores the long-term potential of NIR imaging.
For example, the Stryker SPY Portable
Handheld Imager (SPY-PHI) leverages near-infrared fluorescence imaging combined
with Stryker’s SPY agent green to assist surgeons during breast cancer
procedures. The system enables visualization of lymph nodes, supporting
lymphatic mapping and potentially reducing the need for more invasive
interventions.
Download Sample PDF Copy: https://meditechinsights.com/near-infrared-imaging-market/request-sample/
Continuous Technological Advancements
The NIR imaging market continues to
benefit from rapid technological progress aimed at improving resolution,
sensitivity, and overall device performance. Notable developments include the
April 2024 launch of LI-COR Biotech’s Odyssey F biomolecular imaging systems,
which offer faster scanning speeds, expanded assay support, and improved data
confidence. Earlier innovations include KARL STORZ’s IMAGE1 S Rubina multimode
visualization system, introduced in January 2021, which combines 4K imaging
with enhanced fluorescence-guided visualization using NIR/ICG technology. In
October 2019, Stryker introduced its SPY-PHI fluorescence imaging technology to
improve safety and outcomes in breast cancer surgery.
United States to Lead the Global Market
The United States is expected to
dominate the global NIR imaging market due to strong investment in medical
research infrastructure, a high rate of adoption of advanced diagnostic
technologies, and a robust innovation ecosystem. Demand is particularly strong
in oncology and neurology applications. The presence of leading market players,
substantial public and private R&D funding, and supportive government
initiatives continue to accelerate technological advancements. Collaborative
efforts between academic institutions and industry players further enhance
system accuracy and efficiency, positioning the U.S. as a key driver of global
market growth.
Product Type Insights
The NIR imaging market is segmented
into NIR imaging devices and NIR imaging agents, probes, and dyes. NIR imaging
devices—such as cameras and spectrometers—account for the largest market share
due to their non-invasive nature and ability to deliver real-time imaging
during procedures including cancer detection, tissue imaging, and vascular
assessment. Continued improvements in resolution, portability, and system
integration reinforce their market dominance.
In contrast, the market for NIR
imaging agents and dyes is comparatively smaller, largely due to stringent
regulatory approval processes and the need for continuous innovation to enhance
specificity and reduce toxicity. Nevertheless, growing demand for precise,
non-invasive diagnostics and advances in molecular imaging continue to support
growth in this segment.
Application Segment Analysis
By application, the NIR imaging market
includes preclinical imaging, cancer surgeries, gastrointestinal surgeries,
cardiovascular surgeries, and other applications. Cancer surgeries represent the
largest segment, driven by NIR imaging’s ability to provide high-contrast
visualization of malignant tissue. This capability improves tumor localization,
enables accurate margin assessment, reduces recurrence risk, and preserves
healthy tissue. The rising global incidence of cancer and the development of
targeted imaging agents that selectively bind to cancer cells are further
strengthening adoption. Integration with robotic-assisted surgical systems is
also contributing to increased use in oncological procedures.
Browse Full Report: https://meditechinsights.com/near-infrared-imaging-market/
Competitive Landscape
The global NIR imaging market features
several established players, including Stryker, KARL STORZ SE & Co. KG,
Carl Zeiss Meditec AG, Leica Microsystems, Olympus Corporation, Medtronic plc,
PerkinElmer, LI-COR, Shimadzu Corporation, and Hamamatsu Corporation.
Growth Strategies Adopted by Market Players
Market participants are actively
pursuing both organic and inorganic growth strategies, including product
launches, partnerships, and acquisitions. Recent developments include Abbott’s
October 2023 launch of a near-infrared-based vascular imaging platform in
India, Olympus Corporation’s September 2022 introduction of the VISERA ELITE
III surgical endoscopy system, and Shimadzu’s August 2022 release of the
LuminousQuester NI system for nonclinical research applications. These
initiatives are expected to further strengthen market momentum.
Related Report:
· Nanomedicine
Market - https://www.pharmiweb.com/press-release/2025-12-04/nanomedicine-market-insights-and-growth-opportunities-in-2025-an-extensive-analysis-2030
· Alzheimer’s
Drugs Market - https://www.pharmiweb.com/press-release/2025-12-04/weight-management-market-trends-investment-opportunities-and-growth-analysis-through-2030
· Healthcare
Cloud Computing Market - https://www.pharmiweb.com/press-release/2025-12-04/healthcare-cloud-computing-market-set-to-witness-significant-growth-by-2025-2030
· Weight
Management Market - https://www.pharmiweb.com/press-release/2025-12-04/weight-management-market-trends-investment-opportunities-and-growth-analysis-through-2030
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis & go-to-market
strategy. Our methodology includes rigorous secondary research combined with
deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side
decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment